|
Volumn 37, Issue 1, 2005, Pages 201-204
|
Facial tissue allograft transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CD4 ANTIGEN;
CD45 ANTIGEN;
CD8 ANTIGEN;
CYCLOSPORIN;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;
MEGLUMINE;
MEGLUMINE FLUNIXIN;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
B LYMPHOCYTE;
CHIMERA;
CONFERENCE PAPER;
CONTROLLED STUDY;
DONOR;
FACE;
FLOW CYTOMETRY;
FUNCTIONAL ASSESSMENT;
GRAFT REJECTION;
GRAFT SURVIVAL;
IMMUNOLOGICAL TOLERANCE;
IMMUNOREACTIVITY;
IMMUNOSUPPRESSIVE TREATMENT;
ISOGRAFT;
MAJOR HISTOCOMPATIBILITY COMPLEX;
MONOTHERAPY;
NONHUMAN;
POSTOPERATIVE COMPLICATION;
POSTOPERATIVE PAIN;
POSTOPERATIVE PERIOD;
PRIORITY JOURNAL;
RAT;
RECIPIENT;
SKIN ALLOGRAFT;
T LYMPHOCYTE SUBPOPULATION;
TISSUE GRAFT;
|
EID: 16244394053
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.12.055 Document Type: Conference Paper |
Times cited : (22)
|
References (6)
|